Oat β-glucan ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice

Food and Function

Volumn 6, Issue 11, 2015, Pages 3454-3463

  Liu, Bo ^a   Lin, Qinlu ^a   Yang, Tao ^a   Zeng, Linna ^a   Shi, Limin ^a   Chen, Yaya ^a   Luo, Feijun ^a  

^a CENTRAL SOUTH UNIVERSITY OF FORESTRY AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGY; MAMMALS; NITRIC OXIDE; SODIUM; SULFUR COMPOUNDS;

ANTI-INFLAMMATORY FUNCTION; DEXTRAN SULFATE SODIUM; GASTROINTESTINAL TRACT; INFLAMMATORY BOWEL DISEASE; PROTECTIVE EFFECTS; PROTEIN EXPRESSIONS; SYSTEM ACTIVATION; ULCERATIVE COLITIS;

DISEASES;

BETA GLUCAN; CYTOKINE; DEXTRAN SULFATE; MALONALDEHYDE; MESSENGER RNA; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE; PROTECTIVE AGENT;

ANIMAL; AVENA; CHEMICALLY INDUCED; CHEMISTRY; COLITIS, ULCERATIVE; COLON; DIARRHEA; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; PATHOLOGY; PHYTOTHERAPY; RANDOMIZATION; SPLEEN; WEIGHT REDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AVENA; BETA-GLUCANS; COLITIS, ULCERATIVE; COLON; CYTOKINES; DEXTRAN SULFATE; DIARRHEA; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; NITRIC OXIDE; PEROXIDASE; PHYTOTHERAPY; PROTECTIVE AGENTS; RANDOM ALLOCATION; RNA, MESSENGER; SPLEEN; WEIGHT LOSS;

EID: 84946568515     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c5fo00563a     Document Type: Article

References (47)

1. D. C. Baumgart S. R. Carding Inflammatory bowel disease: cause and immunobiology Lancet 2007 369 1627 1640
2. D. C. Baumgart W. J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 2007 369 1641 1657
3. G. Bouma W. Strober The immunological and genetic basis of inflammatory bowel disease Nat. Rev. Immunol. 2003 3 521 533
4. M. A. McGuckin R. Eri L. A. Simms G. Radford-Smith et al., Intestinal barrier dysfunction in inflammatory bowel diseases Inflamm. Bowel. Dis. 2009 15 100 113
5. R. V. Bryant O. Brain S. P. Travis Conventional drug therapy for inflammatory bowel disease Scand. J. Gastroenterol. 2015 50 90 112
6. I. Okayasu S. Hatakeyama M. Yamada et al., A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 1990 98 694 702
7. E. J. Cho J. S. Shin K. S. Chung et al., Arvelexin inhibits colonic inflammation by suppression of NF-κB activation in dextran sulfate sodium-induced mice and TNF-α-induced colonic epithelial cells J. Agric. Food Chem. 2012 60 7398 7407
8. H. González-Mauraza C. Martín-Cordero C. Alarcón-de-la-Lastra et al., Anti-inflammatory effects of Retama monosperma in acute ulcerative colitis in rats J. Physiol. Biochem. 2014 70 163 172
9. F. Algieri A. Rodriguez-Nogales N. Garrido-Mesa et al., Intestinal anti-inflammatory activity of the Serpylli herba extract in experimental models of rodent colitis J. Crohns Colitis 2014 8 775 788
10. S. H. Albeituni J. Yan The effects of β-glucans on dendritic cells and implications for cancer therapy Anticancer Agents Med. Chem. 2013 13 689 698
11. D. L. Williams Overview of (1-3)-beta-d-glucan immunobiology Med. Inflamm. 1997 6 247 250
12. A. O. Tzianabos Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function Clin. Microbiol. Rev. 2000 13 523 533
13. D. B. Zeković S. Kwiatkowski M. M. Vrvić et al., Natural and modified (1R3)-beta-d-glucans in health promotion and disease alleviation Crit. Rev. Biotechnol. 2005 25 205 230
14. A. Rychlik R. Nieradka M. Kander et al., The effectiveness of natural and synthetic immunomodulators in the treatment of inflammatory bowel disease in dogs Acta Vet. Hung. 2013 61 297 308
15. S. Jawhara K. Habib F. Maggiotto et al., Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions PLoS One 2012 7 e40648
16. H. Takedatsu K. Mitsuyama S. Mochizuki et al., A new therapeutic approach using a schizophyllan-based drug delivery system for inflammatory bowel disease Mol. Ther. 2012 20 1234 1241
17. Y. Nishitani L. Zhang M. Yoshida et al., Intestinal anti-inflammatory activity of lentinan: influence on IL-8 and TNFR1 expression in intestinal epithelial cells PLoS One 2013 8 e62441
18. P. P. Zhang X. Z. Hu H. M. Zhen et al., Oat β-glucan increased ATPases activity and energy charge in small intestine of rats J. Agric. Food Chem. 2012 60 9822 9827
19. N. Lin Y. Li L. Tang et al., In vivo effect of oat cereal β-glucan on metabolic indexes and satiety-related hormones in diet-induced obesity C57-Bl mice Mol. Nutr. Food Res. 2013 57 1291 1294
20. C. J. Rebello Y. F. Chu W. D. Johnson et al., The role of meal viscosity and oat β-glucan characteristics in human appetite control: a randomized crossover trial Nutr. J. 2014 13 49 59
21. S. You X. Hu Q. Zhao et al., Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice Food Funct. 2013 4 1360 1368
22. R. C. Schwanke R. Marcon F. C. Meotti et al., Oral administration of the flavonoid myricitrin prevents dextran sulfate sodium-induced experimental colitis in mice through modulation of PI3 K/Akt signaling pathway Mol. Nutr. Food Res. 2013 57 1938 1949
23. L. R. Fitzpatrick J. Wang M. Le In vitro and in vivo effects of gliotoxin, a fungal metabolite: Efficacy against dextran sodium sulfate-induced colitis in rats Dig. Dis. Sci. 2000 45 2327 2336
24. H. S. Cooper S. N. Murthy R. S. Shah et al., Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab. Invest. 1993 69 238 249
25. J. L. Song Y. Qian G. J. Li X. Zhao Anti-inflammatory effects of kudingcha methanol extract (Ilex kudingcha C. J. Tseng) in dextran sulfate sodium-induced ulcerative colitis Mol. Med. Rep. 2013 8 1256 1262
26. B. L. Xu G. J. Zhang Y. B. Ji Active components alignment of Gegenqinlian decoction protects ulcerative colitis by attenuating inflammatory and oxidative stress J. Ethnopharmacol. 2015 162 253 260
27. K. M. Miranda M. G. Espey D. A. Wink A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite Nitric. Oxide 2001 5 62 71
28. F. Algieri A. Rodriguez-Nogales N. Garrido-Mesa et al., Intestinal anti-inflammatory activity of the Serpylli herba extract in experimental models of rodent colitis J. Crohns Colitis 2014 8 775 788
29. W. Dou J. Zhang G. Ren et al., Mangiferin attenuates the symptoms of dextran sulfate sodium-induced colitis in mice via NF-κB and MAPK signaling inactivation Int. Immunopharmacol. 2014 23 1 170 178
30. Q. Wang P. R. Ellis Oat β-glucan: physico-chemical characteristics in relation to its blood-glucose and cholesterol-lowering properties Br. J. Nutr. 2014 112 Suppl 2 S4 S13
31. I. D. Nwachukwu J. G. Devassy R. E. Aluko Cholesterol-lowering properties of oat β-glucan and the promotion of cardiovascular health: did Health Canada make the right call? Appl. Physiol. Nutr. Metab. 2015 27 1 8
32. P. P. Zhang X. Z. Hu H. M. Zhen et al., Oat β-glucan increased ATPases activity and energy charge in small intestine of rats J. Agric. Food Chem. 2012 60 9822 9827
33. N. Lin Y. Li L. Tang et al., In vivo effect of oat cereal β-glucan on metabolic indexes and satiety-related hormones in diet-induced obesity C57-Bl mice Mol. Nutr. Food Res. 2013 57 1291 1294
34. J. Zhao T. Hong M. Dong et al., Protective effect of myricetin in dextran sulphate sodium-induced murine ulcerative colitis Mol. Med. Rep. 2013 7 565 570
35. A. Asgharpour J. Cheng S. J. Bickston Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial Clin. Exp. Gastroenterol. 2013 30 153 160
36. O. Ludwiczek E. Vannier I. Borggraefe et al., Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease Clin. Exp. Immunol. 2004 138 323 329
37. F. Cominelli C. C. Nast B. D. Clark et al., Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis J. Clin. Invest. 1990 86 972 980
38. M. E. McAlindon C. J. Hawkey Y. R. Mahida Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease Gut 1998 42 214 219
39. J. Rugtveit P. Brandtzaeg T. S. Halstensen et al., Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes Gut 1994 35 669 674
40. C. A. Dinarello S. M. Wolff The role of interleukin-1 in disease N. Engl. J. Med. 1993 328 106 113
41. K. A. Roebuck J. J. Jacobs T. T. Glant New horizons in orthopaedic research, elucidation of cellular signal transduction pathways J. Bone Joint Surg. Am. 1999 81 599 602
42. O. H. Nielsen New strategies for treatment of inflammatory bowel disease Front. Med. 2014 24 1 3
43. J. Petersson O. Schreiber A. Steege et al., eNOS involved in colitis-induced mucosal blood flow increase Am. J. Physiol. Gastrointest. Liver Physiol. 2007 293 1281 1287
44. M. J. Miller J. H. Thompson X. J. Zhang et al., Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis Gastroenterology 1995 109 1475 1483
45. K. Palatka Z. Serfozo Z. Veréb et al., Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease Scand. J. Gastroenterol. 2005 40 670 680
46. O. Schreiber J. Petersson T. Waldén et al., iNOS-dependent increase in colonic mucus thickness in DSS-colitic rats PLoS One 2013 8 8 e71843
47. K. Ishibashi N. N. Miura Y. Adachi et al., Relationship between solubility of grifolan, a fungal 1,3-beta-d-glucan, and production of tumor necrosis factor by macrophages in vitro Biosci., Biotechnol., Biochem. 2001 65 1993 2000